tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

research

0

Secrets of Success: How EPI-Q Does Real-World Research Really Well

Posted on May 22, 2014 by Patti Peeples, R.Ph., Ph.D.

Nothing beats experience.  Well, maybe a list of secrets learned from that experience, compiled directly from an expert!  And that’s what you’ll get here, in today’s blog post. I recently conducted a podcast with Dr. Mark Jewell, President of EPI-Q,… Continue Reading →

Real-World Evidence Accountable care organizations, ACOs, administrative claims databases, comparative effectiveness research, consulting, EPI-Q, Evidence-based medicine, health economics, health outcomes liaisons, HEOR, IDNs, Integrated delivery networks, mark jewell, outcomes research, patient reported outcomes, payers, pharmaceutical market access, pharmaceutical marketing, Real-world evidence, research, RWE

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • How Accelerated Drug Development Requires Disruption in Market Access and Pricing
  • The UK market access has always been complex, now even more than before, Graham Foxon and Paul Craddy?
  • How to Change Clinical Practice Using Health Economics and Outcomes Research
  • Switzerland is strong in many aspects, so also in its health care system, Dr. Peter Indra?

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

www_healthecon
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
37m

Pharma Voice Woman of the Week: Miruna Sasu, President and CEO of COTA

http://ow.ly/PK8150KijNZ

#HEOR #RWE #RWD #Pharma #Biotech

Reply on Twitter 1557872227982491648 Retweet on Twitter 1557872227982491648 Like on Twitter 1557872227982491648 Twitter 1557872227982491648
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
2h

Essential Terms for UK Quality Regulations Post-Brexit

http://ow.ly/QmFb50KihON

#HEOR #Pharma #UK #HTA #Biotech

Reply on Twitter 1557848706380341248 Retweet on Twitter 1557848706380341248 Like on Twitter 1557848706380341248 Twitter 1557848706380341248
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
4h

Pharma Preps Legal Strategy Against New US Drug Pricing Regulation

http://ow.ly/ITj550Kieg8

#HEOR #Pharma #DrugPrices #Biotech

Reply on Twitter 1557825628900134912 Retweet on Twitter 1557825628900134912 Like on Twitter 1557825628900134912 1 Twitter 1557825628900134912
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2022 tHEORetically Speaking. All rights reserved.
Hiero by aThemes